Raphael Pharmaceutical RAPH
OTC RAPH
$1.40 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

Raphael Pharmaceutical (RAPH) Change in Other Operating Liabilities (2024 - 2025)

Updated

Analysis

Raphael Pharmaceutical (RAPH) Change in Other Operating Liabilities (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,132.21 Bn 1,100.80 Bn 19.71 Bn -
2 Johnson & Johnson 616.27 Bn 534.80 Bn 17.26 Bn -972.00 Mn
3 AbbVie 500.10 Bn 473.21 Bn 12.70 Bn -
4 Merck 366.86 Bn 321.23 Bn 12.21 Bn -
5 Novartis Ag 297.92 Bn 261.91 Bn 11.24 Bn -
6 Astrazeneca 261.53 Bn 235.22 Bn 12.86 Bn -
7 Amgen 234.99 Bn 190.39 Bn 7.24 Bn -32.00 Mn
8 Gilead Sciences 190.14 Bn 164.34 Bn 6.22 Bn -
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn -112.00 Mn
10 Raphael Pharmaceutical 28.25 Mn 28.18 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 291,000.00
Sep 30, 2025 191,000.00
Dec 31, 2024 -405,000.00
API Access

Raphael Pharmaceutical Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=RAPH&period=max&api_key=YOUR_API_KEY